THY1 and liver cancer: Both cell line-derived CD90+ cells and liver cancer patient tissue-/blood-derived CD45− CD90+ cells generate tumor nodules in immunodeficient mice, and serial transplantation of xenografts derived from CD90+ cells produces tumor nodules in a second and subsequently third batch of immunodeficient mice [6].